Radioiodine after thyroidectomy did not improve outcomes in patients with low-risk thyroid cancer.
For patients with low-risk thyroid cancer undergoing thyroidectomy, follow-up without use of radioiodine is noninferior to ablation with radioiodine.
The complete response rate was similar for patients who received selumetinib and those who received radioactive iodine alone.
The multimodal AI platform proved more accurate than deep learning alone.
The recurrence of thyroid cancer is traditionally predicted using clinical tools. A more detailed way to predict recurrence is currently being researched.
Fine needle biopsy is the standard diagnostic test for indeterminate thyroid nodules, but increases medical costs and causes anxiety in patients. Researchers explored whether targeted use of Thyroid Imaging, Reporting, and Data System (TI-RADS) could provide faster and less-invasive diagnoses.
A connection between follicular thyroid cancer postthyroidectomy and cardiovascular disease is unknown. Researchers studied the records of almost 350 people to find out more.
Investigators studied the bones of adults who had thyroid cancer as children to find out if treatment for the disease carried consequences into adulthood.
Obesity rates and the incidence of malignant thyroid nodules have been increasing among younger patients in the US; there may be an association.
A single preoperative dose of dexamethasone reduces rates of postoperative hypocalcemia and voice dysfunction in patients undergoing thyroidectomy.
While calcitonin is considered standard of care for the diagnosis and follow-up of medullary thyroid cancer, researchers may have found a potentially more reliable marker.